MedTrace Logo

Imaging of Osteonecrosis With Ferumoxytol-Enhanced MRI

NCT02893293 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2024-11-26

Study results available
· View outcomes & findings →

Summary

The goal of the project is to evaluate osteonecrosis before and after decompression surgery with ferumoxytol-enhanced MRI.

Conditions

  • Osteonecrosis

Interventions

DRUG

Ferumoxytol-enhanced magnetic resonance imaging

Eligible patients receive a single ferumoxytol-dose and follow-up magnetic resonance imaging to evaluate success of stem cell transplant

DEVICE

Magentic Resonance Imaging

Both arms will receive MRI

Sponsors & Collaborators

Principal Investigators

  • Heike Daldrup-Link, MD, PhD · Stanford University

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
8 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2023-10-31
Completion
2023-10-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02893293 on ClinicalTrials.gov